Cite
HARVARD Citation
Laetsch, T. et al. (2023). Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial. Journal of clinical oncology. 41 (9), pp. 1664-1669. [Online].